Autologous Transplantation and Maintenance Therapy in Multiple Myeloma-Reference-Cited by-同舟云学术

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Published:2014-09-04 Issue:10 Volume:371 Page:895-905
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Palumbo Antonio,Cavallo Federica,Gay Francesca,Di Raimondo Francesco,Ben Yehuda Dina,Petrucci Maria Teresa,Pezzatti Sara,Caravita Tommaso,Cerrato Chiara,Ribakovsky Elena,Genuardi Mariella,Cafro Anna,Marcatti Magda,Catalano Lucio,Offidani Massimo,Carella Angelo Michele,Zamagni Elena,Patriarca Francesca,Musto Pellegrino,Evangelista Andrea,Ciccone Giovannino,Omedé Paola,Crippa Claudia,Corradini Paolo,Nagler Arnon,Boccadoro Mario,Cavo Michele

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1402888

Cited by 654 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database;Transplantation and Cellular Therapy;2024-09

2. Does immunohistochemical staining predict mobilization success in multiple myeloma patients?;Transfusion and Apheresis Science;2024-09

3. The emerging role of melflufen and peptide-conjugates in multiple myeloma;Current Opinion in Oncology;2024-08-22

4. Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial;The Lancet Oncology;2024-08

5. Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades;Transplantation and Cellular Therapy;2024-08